• 19/11/2024

    KNCV took part at the Union World Conference 2024

    Another year in which KNCV Tuberculosis Foundation (KNCV) positions as a…

    Lees meer
  • 05/11/2024

    Novel TB skin test (SIILTIBCY) receives positive opinion from European Medicines Agency (EMA)

    In a significant step for global health, Serum Life Science Europe GmbH (SLS Europe) and the…

    Lees meer
  • 30/10/2024

    TB continues to be the world’s leading infectious disease killer: WHO Global TB Report 2024

    The World Health Organization (WHO) has just released its Global Tuberculosis (TB) Report 2024,…

    Lees meer
  • 28/10/2024

    Workshop “Sharing experiences and practical lessons in scale-up, introduction and innovation of stool-based testing to diagnose TB, zooming in on Asia.”

    On Tuesday 12 of November, during the Union World Conference on Lung Health 2024 we will facilitate…

    Lees meer
  • 22/10/2024

    AI technology brigdes knowledge gaps on tuberculosis

    Given recent advances in technology, such as Artificial Intelligence (AI) and AI-enabled chatbots, a personalized digital interface that simulates conversations…

    Lees meer
  • 11/10/2024

    Eight political parties commit to global health and SRHR at launch of multiparty initiative

    On Friday 4 October, the multiparty initiative on global health and sexual and reproductive…

    Lees meer
  • 30/09/2024

    Why global health, pandemic preparedness and gender equality should be part of the Dutch political agenda

    Today starts Advocacy week! A week in which KNCV, together with its partners, emphasizes the importance of the role of…

    Lees meer
  • 18/09/2024

    Implementing shorter TPT regimens, the experience of Indonesia, Ethiopia and Tanzania

    The journey to ending tuberculosis (TB) has taken a significant leap forward with projects like the Unitaid…

    Lees meer
  • 06/09/2024

    Tuberculosis-related stigma in healthcare workers and facilities

    Stigma is a complex social issue that arises when certain attributes, such as being diagnosed with tuberculosis (TB) or other…

    Lees meer
  • 30/08/2024

    New TB vaccines could save millions of lives

    On August 22, 2024 PLOS Global Public Health published the research paper titled “Mapping the existing body…

    Lees meer
  • 23/08/2024

    ReACT Asia Pacific Conference on Antimicrobial Resistance (AMR) – August 202

    On August 21st and 22nd, the ReACT Asia Pacific Conference on Antimicrobial Resistance (AMR) took place in Jakarta under the…

    Lees meer
  • 05/08/2024

    Visit the historical exhibition of former tuberculosis sanatorium Zonnestraal in Hilversum, the Netherlands

    National monument Zonnestraal in Hilversum, the Netherlands, has set up an exhibition on the history of…

    Lees meer
  • 22/07/2024

    KNCV Looks Forward into 2024

    KNCV Tuberculosis Foundation recently published the Annual Report 2023. With the learnings and achievements from 2023, KNCV…

    Lees meer
  • 09/07/2024

    Learnings from the Nigerian Experience: Operating GeneXpert® in challenging settings

    On July 2nd we hosted a webinar on Lessons Learned from the Nigerian Experience Operating GeneXpert® in Challenging Settings.

    Lees meer
  • 01/07/2024

    KNCV’s TB Expert is appointed Vice-Chair of the WHO TB Public-Private Mix Core Group

    “Together, we aim to drive forward innovative strategies and strengthen our global efforts to end TB.” – Dr. Vijayashree Yellappa…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.